Life Science Access Academy Ltd invites you to their event
About this event
At its core, the value proposition of pharmaceutical products is deeply entwined with their capacity to diagnose, treat and prevent diseases – a vital consideration in health technology appraisal (HTA).
In these assessments, a sharp focus is demanded on evidence demonstrating therapeutic value and economic benefits, with increasing focus on humanistic and societal value.
The innovation inherent in pharmaceuticals is also a focal point during these evaluations, reflecting the industry's commitment to introducing novel therapies and treatment modalities that align with evolving healthcare needs.
Join us in this informative 60-minute masterclass for LSAA members and hear from experts at Initiate.
Hosted by
Jonathan is a Market Access Consultant within the Value, Access, and Pricing team at Initiate consultancy. He has expertise in the translation of complex scientific information into value that is demonstratable to HTA bodies. His previous experiences cover the development of global value dossiers and other value tools, evidence generation activities, and acting within an evidence review group for Australasian HTA authorities.
Adelaide is a Senior Consultant in the value, access and pricing team at Initiate. She has over five years of experience in market access consulting, with particular expertise in value communication, stakeholder engagement, evidence generation and strategic recommendations for market access.
Jane is Head of Value, Access and Pricing at Initiate, a best-in-class market access and health economics and outcomes research (HEOR) consultancy. She has over a decade of experience with significant expertise in value demonstration and HEOR strategy across a range of therapy areas.
Ian co-founded the Life Science Access Academy with Nigel Robbins to bring together all the best ideas in people development from more than 20 innovative specialist consultancies.
LSAA is a truly Global Membership Community for all staff from across the Life Science sector including: commercial, clinical and financial sales teams, medics and support teams.
